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ABSTRACT 
Astrocytes, a type of cell in the brain, become activated in response to 
brain injury that increases their rates of migration and growth, responses that are 
collectively termed reactive astrogliosis.    Although there are indications that 
reactive astrocytes can protect undamaged tissue and limit secondary injury, 
excessive or chronic accumulation of astrocytes can produce inflammation and 
prevent regeneration of neurons within the damaged area. Therefore, a greater 
understanding of the mechanisms involved in reactive astrogliosis should provide 
new ways to prevent irreversible brain damage in neurological disorders. 
Damage to brain cells causes the release of cellular nucleotides, such as ATP 
and UTP, whereupon they activate a cell surface receptor called the P2Y2 
nucleotide receptor (P2Y2R) that mediates responses associated with reactive 
astrogliosis.  Results in this study with primary rat astrocytes indicate that P2Y2R 
activation increases cell migration.  UTP-induced astrocyte migration was 
inhibited by silencing of P2Y2R expression with P2Y2R siRNA, providing direct 
evidence that the P2Y2R is involved.  UTP also increased the expression in 
astrocytes of integrins called αVβ3/5 that are known to bind the P2Y2R to modulate 
its function.  Anti-αV integrin antibodies prevented UTP-stimulated astrocyte 
migration, suggesting that P2Y2R/αV interaction is required for this effect.  
P2Y2R-mediated astrocyte migration required the activation of intracellular 
kinases including the PI3-K/Akt and MEK/ERK signaling pathways, responses 
that also were inhibited by anti-αV integrin antibody.  These results suggest that 
P2Y2Rs and their associated signaling pathways may be important factors 
regulating inflammation in brain disorders.    
